DHR vs HON: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Honeywell International Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-14.
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
VS
Honeywell International Inc. · Industrials
$222.25
-5.5% upside to fair value
Grade D
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+7.9%).
HON trades at a lower forward P/E
(15.7x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
HON |
| Current Price |
$195.98 |
$222.25 |
| Fair Value Estimate |
$211.54 |
$210.05 |
| Upside to Fair Value |
+7.9%
|
-5.5%
|
| Market Cap |
$138.7B |
$70.4B |
| Forward P/E |
37.8x
|
15.7x
|
| EV / EBITDA |
22.8x
|
13.1x
|
| Price / Sales |
5.6x
|
1.9x
|
| Price / FCF |
26.2x
|
17.1x
|
| Revenue Growth YoY |
+3.7%
|
-6.9%
|
| Gross Margin |
60.7%
|
36.9%
|
| Operating Margin |
21.0%
|
14.9%
|
| Return on Equity |
7.1%
|
23.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.81%
|
5.84%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Honeywell International Inc. operates as a diversified industrial conglomerate with a strong presence in multiple sectors including aerospace, building technologies, and performance materials. The company demonstrates high business quality with a durable competitive moat supported by strong margins, a 23.6% return on equity, and solid free cash flow generation of $16.78 per share. However, recent…
Accumulation Zones
| Metric |
DHR |
HON |
| Zone Low |
$158.66 |
$157.54 |
| Zone High |
$179.81 |
$178.54 |
| In Buy Zone? |
No
|
No
|